NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $3,475,000 | +33.7% | 51,600 | +67.3% | 0.78% | +81.6% |
Q4 2019 | $2,599,000 | -39.3% | 30,847 | -75.9% | 0.43% | -52.2% |
Q4 2018 | $4,285,000 | -61.9% | 127,973 | -40.3% | 0.90% | -51.1% |
Q3 2018 | $11,236,000 | +43.2% | 214,431 | -14.5% | 1.84% | +38.2% |
Q2 2018 | $7,849,000 | – | 250,769 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |